A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation

Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF–triggered granulopoiesis

(2012) Julia Skokowa et al.   NATURE MEDICINE

Secretory Leukocyte Protease Inhibitor (SLPI) Expression and Tumor Invasion in Oral Squamous Cell Carcinoma

(2011) Jie Wen et al.   AMERICAN JOURNAL OF PATHOLOGY

Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane

(2011) S. Nanua et al.   BLOOD

Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells

(2011) Ebony Hoskins et al.   GYNECOLOGIC ONCOLOGY

Secretory Leukocyte Protease Inhibitor Antagonizes Paclitaxel in Ovarian Cancer Cells

(2010) N. Rasool et al.   CLINICAL CANCER RESEARCH

Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis

(2010) Devipriya SUBRAMANIYAM et al.   RESPIROLOGY

Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1

(2009) J. Skokowa et al.   BLOOD

PLZF is a regulator of homeostatic and cytokine-induced myeloid development

(2009) S. Doulatov et al.   GENES & DEVELOPMENT

NAMPT is essential for the G-CSF–induced myeloid differentiation via a NAD+–sirtuin-1–dependent pathway

(2009) Julia Skokowa et al.   NATURE MEDICINE

The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils

(2008) Lars C. Jacobsen et al.   JOURNAL OF LEUKOCYTE BIOLOGY